Info

Bullseye Brief

A spirited conversation for thoughtful investors with Adam Johnson of Bullseye Brief.
RSS Feed Subscribe in Apple Podcasts
Bullseye Brief
2020
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August


Categories

All Episodes
Archives
Categories
Now displaying: February, 2020
Feb 26, 2020

From stone-washed denim in the 80s, to bio-fuels in the 90s, and now a potential cure for Corona, CEO Mark Emalfarb of Dyadic Int'l Inc. (DYAI) has long championed using fast-growing fungal cells to develop biologic solutions at a massive scale... with significant cost-savings. I call it American Ingenuity in the service of humanity. Tune in for:

  • How repurposed fungal cells make drugs.
  • Why companies and countries are signing on.
  • What this means for healthcare in the long run.
Feb 12, 2020

Imagine owning a hard asset which has risen in value 95 of the last 100 years, pays a 5% dividend and has no correlation to the stock market. Interesting, right? It's called peace of mind, and large pension funds are big buyers. My friend Edward Hargroves of Goldcrest Farm Trust explains.

  • How institutions acquire property
  • What farmers get in return
  • Why the "I"s are hot  (IA, IL, IN)
  • Where all this is going
1